✦ LIBER ✦

Lapatinib plus capecitabine versus capecitabine alone for ErbB2-positive metastatic breast cancer (MBC) – Quality of Life (QOL) assessment

✍ Scribed by X. Zhou; A. Segreti; D. Cella; D. Cameron; C. Geyer; M. Amonkar; S. Stein; M. Walker

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lapatinib plus capecitabine versus capec

✍ Xiaolei Zhou; David Cella; David Cameron; Mayur M. Amonkar; Anthony Segreti; Ste 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 534 KB

Lapatinib plus paclitaxel versus paclita

✍ Y. Wu; A. Segreti; D. Cella; A. DiLeo; M. Amonkar; M. Koehler; M. Arbushites; M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

2140 POSTER A comparison of lapatinib pl

✍ B. Sherrill; A. Allshouse; M.M. Amonkar; M.D. Walker; S.H. Stein 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

410 POSTER Quality of life (QoL) improve

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

446 Quality of life (QoL) in patients wi

✍ G. Segalla; C.T. Oliveira; S. Lago; R. Ribeiro; R. Guimarães; S. Cabral; G. Letc 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

PCN23 COST-EFFECTIVENESS ANALYSIS OF LAP

✍ F Ejzykowicz; JW Hay 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB